Waters Announce Malaysian Expansion
Waters Corporation has announced the opening of a new Solution Centre in Petaling Jaya, Selangor, Malaysia. The new facility is designed to advance liquid chromatography and mass spectrometry analytical capabilities, developing new applications and offering training to scientists within its demonstration and training facilities.
Waters Corporation has announced the opening of a new Solution Centre in Petaling Jaya, Selangor, Malaysia. The new facility is designed to advance liquid chromatography and mass spectrometry analytical capabilities, developing new applications and offering training to scientists within its demonstration and training facilities.
“This is another milestone for us to better support customers for their LC–MS applications and their education needs,” said Mathieu Laouenan, General Manager - SEA & Australasia, Waters Pacific Pte Ltd.
“Delivering benefit is Waters’ core value. The investment in this new Solution Centre reinforces that commitment to our customers. Scientists can now choose the right technology platform for their laboratories through firsthand experiences with Waters technologies, as well as continued training and support after a purchase is made,” said Krishna Kodoth, General Manager - Malaysia, Waters Analytical Instruments Sdn. Bhd.
The new Solution Centre further strengthens Waters’ presence in Malaysia building on offices and subsidiaries previously developed to take advantage of Malaysia’s growing bioprocessing market.
For more information please visit www.waters.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
